http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019508421-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-06 |
| filingDate | 2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019508421-A |
| titleOfInvention | Pharmaceutical composition for treating growth hormone deficiency comprising recombinant hGH |
| abstract | The present invention relates to a method of administration of human growth hormone fusion protein, GX-H9, to treat growth hormone deficiency. Specifically, the present invention comprises hGH fusion protein GX-H9 and a pharmaceutically acceptable carrier, wherein said fusion protein (GX-H9) is 0.1-0.3 mg per kg patient weight The present invention relates to a pharmaceutical composition for treating growth hormone deficiency, which is administered once weekly at a dose or once every two weeks at a dose of 0.1 to 0.4 mg / kg of the patient's body weight. In addition, the present invention administers hGH fusion protein GX-H9 at a dose of 0.1 to 0.3 mg / kg of patient weight once a week to patients with growth hormone deficiency, or the patient's weight kg The present invention relates to a method of treating growth hormone deficiency, which comprises administering twice a week at a dose of 0.1 to 0.4 mg per dose. [Selected figure] Figure 10 |
| priorityDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.